Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
Farmers Insurance
Johnson and Johnson
Novartis
AstraZeneca
Moodys
Teva
Harvard Business School
Healthtrust
Baxter

Generated: December 12, 2017

DrugPatentWatch Database Preview

SODIUM PHENYLBUTYRATE Drug Profile

« Back to Dashboard

When do Sodium Phenylbutyrate patents expire, and when can generic versions of Sodium Phenylbutyrate launch?

Sodium Phenylbutyrate is a drug marketed by Par Pharm, Sigmapharm Labs Llc, and Alvogen Malta. and is included in four NDAs.

The generic ingredient in SODIUM PHENYLBUTYRATE is sodium phenylbutyrate. There are one thousand four hundred drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the sodium phenylbutyrate profile page.
Drug patent expirations by year for SODIUM PHENYLBUTYRATE

Pharmacology for SODIUM PHENYLBUTYRATE

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Par PharmSODIUM PHENYLBUTYRATEsodium phenylbutyratePOWDER;ORAL203918-001Jun 15, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Par PharmSODIUM PHENYLBUTYRATEsodium phenylbutyrateTABLET;ORAL204395-001Apr 15, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Sigmapharm Labs LlcSODIUM PHENYLBUTYRATEsodium phenylbutyratePOWDER;ORAL202819-001Mar 22, 2013ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Alvogen MaltaSODIUM PHENYLBUTYRATEsodium phenylbutyrateTABLET;ORAL090910-001Nov 18, 2011ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Chubb
McKinsey
AstraZeneca
Covington
Healthtrust
Dow
Citi
Boehringer Ingelheim
Cipla
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot